![Ye Liu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ye Liu
Vorstandsvorsitzender bei
OCUMENSION THERAPEUTICS
Vermögen: 24 Mio $ am 30.06.2026
Profil
Ye Liu currently works at Ocumension Therapeutics, as Chief Executive Officer & Executive Director from 2018.
Mr. Liu also formerly worked at Santen Pharmaceutical (China) Co. Ltd., as Chairman & General Manager from 2014 to 2018, EyePoint Pharmaceuticals, Inc., as Director from 2021 to 2024, Eisai China, Inc., as General Manager from 2009 to 2014, and Sandoz (China) Pharmaceutical Co., Ltd., as Head-Sales from 2006 to 2009.
Mr. Liu received his graduate degree in 2003 from Dalhousie University and undergraduate degree in 1993 from Zhongshan Hospital Fudan University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.09.2025 | 40’918’730 ( 4.89% ) | 24 Mio $ | 30.06.2026 |
Aktive Positionen von Ye Liu
| Unternehmen | Position | Beginn |
|---|---|---|
| OCUMENSION THERAPEUTICS | Vorstandsvorsitzender | 01.08.2018 |
Ehemalige bekannte Positionen von Ye Liu
| Unternehmen | Position | Ende |
|---|---|---|
| EYEPOINT, INC. | Direktor/Vorstandsmitglied | 20.06.2024 |
Santen Pharmaceutical (China) Co. Ltd.
 Santen Pharmaceutical (China) Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales ophthalmic pharmaceuticals | Vorstandsvorsitzender | 01.07.2018 |
Eisai China, Inc.
 Eisai China, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorstandsvorsitzender | 01.09.2014 |
Sandoz (China) Pharmaceutical Co., Ltd.
 Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Engages in the production of generic pharmaceuticals | Vertrieb & Marketing | 01.02.2009 |
Ausbildung von Ye Liu
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
69
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
EyePoint Pharmaceuticals, Inc.
 EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
Dalhousie University
 Dalhousie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Santen Pharmaceutical (China) Co. Ltd.
Santen Pharmaceutical (China) Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales ophthalmic pharmaceuticals | Health Technology |
Eisai China, Inc.
Eisai China, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Zhongshan Hospital Fudan University
 Zhongshan Hospital Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sandoz (China) Pharmaceutical Co., Ltd.
Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Engages in the production of generic pharmaceuticals | Health Technology |
Ocumension Therapeutics
 Ocumension Therapeutics Miscellaneous Commercial ServicesCommercial Services Operates as an ophthalmic pharmaceutical platform company that develops drugs | Commercial Services |
